| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/16/2006 | CA2576949A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 02/16/2006 | CA2576627A1 Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2 |
| 02/16/2006 | CA2574914A1 Organic compounds |
| 02/16/2006 | CA2572752A1 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
| 02/16/2006 | CA2571143A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 02/15/2006 | EP1626059A1 Angiogenic and immunologic applications of anti-CD160 specific compounds obtainable from mAb CL1-R2 |
| 02/15/2006 | EP1626056A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity |
| 02/15/2006 | EP1626048A1 Crystal of benzimidazole derivative and process for producing the same |
| 02/15/2006 | EP1625854A1 Albumin conjugates containing a glucuronic linker |
| 02/15/2006 | EP1625851A1 Preparation for preventing contact of pathogenic matter with living organism |
| 02/15/2006 | EP1625850A1 Immunostimulant |
| 02/15/2006 | EP1625847A1 Pharmaceutical composition comprising a tetrahydrotriazolo[4,3-a]pyrazine |
| 02/15/2006 | EP1625167A1 Hypoallergenic variants of the parietaria judaica major allergens, uses thereof and compositions comprising them |
| 02/15/2006 | EP1625166A1 Antibodies to masp-2 |
| 02/15/2006 | EP1625140A2 Branched immunomodulatory compounds and methods of using the same |
| 02/15/2006 | EP1625127A1 Azaindole compounds as kinase inhibitors |
| 02/15/2006 | EP1625126A1 Imidazo and thiazolopyridines as jak3 kinase inhibitors |
| 02/15/2006 | EP1625123A2 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists |
| 02/15/2006 | EP1624892A2 Therapeutic use of anti-cs1 antibodies |
| 02/15/2006 | EP1487456B1 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions |
| 02/15/2006 | EP1482787A4 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 02/15/2006 | EP1003550B1 Receptor specific transepithelial transport of therapeutics |
| 02/15/2006 | EP0871738B1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 02/15/2006 | CN1735630A Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 02/15/2006 | CN1735629A Single domain antibodies directed against tumor necrosis factor alpha and uses therefor |
| 02/15/2006 | CN1735618A New tricyclic derivatives as LTD4 antagonists |
| 02/15/2006 | CN1735428A Chaperonin 10 immunosuppression |
| 02/15/2006 | CN1735415A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/15/2006 | CN1735414A Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 02/15/2006 | CN1733717A N,N'-biacetylcysteine-diarginine salt isomer and its uses |
| 02/15/2006 | CN1733299A Process for preparing allergoid sublingual buccal vaccine using chitosan as adjuvant |
| 02/15/2006 | CN1733296A Stable liquid interferon formulations |
| 02/15/2006 | CN1733188A Health caring oral liquid with immunoregulation function |
| 02/15/2006 | CN1733103A Process for preparing kidney-tonifying fatigue-eliminating powder, capsule and tablet with micron powder of holoside, ginseng, hippocampus, walnut, pine pollen and antler |
| 02/15/2006 | CN1733053A Capsule of purple sweet potato, its production and application |
| 02/15/2006 | CN1732971A Active sugar composition extracted from sea and bittern, its preparation process and its composition |
| 02/15/2006 | CN1242045C Method for making compound wine containing xylitol, ginseng, colla os cervi and tortoise plastron glue |
| 02/15/2006 | CN1241945C Hybrid protein for inhibiting the deatanulation of mastocytes and the use thereof |
| 02/15/2006 | CN1241912C Disulfide derivatives useful for treating allergic diseases |
| 02/15/2006 | CN1241909C Carboxylic acid derivatives as IP antagonists |
| 02/15/2006 | CN1241638C IFNAR2/I FN complex |
| 02/15/2006 | CN1241637C Preparation of extramembranou section of therapeutic protein B lymphocyte stimulation factor |
| 02/15/2006 | CN1241605C Method for preparing capsule of snail powder |
| 02/15/2006 | CN1241583C Fermented soybean extracted liquid and composite medicine containing the said liquid |
| 02/15/2006 | CN1241575C Cell growth regulating factor U and its preparation process |
| 02/15/2006 | CN1241569C Novel combination of non sedative anti-histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjuncitivitis |
| 02/14/2006 | US6998503 crystallized as an anhydrous, stoichiometric 1.5 HCl salt; inhibiting or modulating nitric oxide synthesis |
| 02/14/2006 | US6998416 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/14/2006 | US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic |
| 02/14/2006 | US6998407 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |
| 02/14/2006 | US6998385 Antiinflammatory agents; autoimmune disease |
| 02/14/2006 | US6998263 Methods of preparing and using a viral vector library |
| 02/14/2006 | US6997863 Thermotherapy via targeted delivery of nanoscale magnetic particles |
| 02/14/2006 | CA2450740C Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/14/2006 | CA2374643C 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists |
| 02/14/2006 | CA2269072C Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/14/2006 | CA2199400C Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases |
| 02/09/2006 | WO2006015124A2 Fused ring heterocycle kinase modulators |
| 02/09/2006 | WO2006013948A1 Triazole derivative |
| 02/09/2006 | WO2006013873A1 Drugs having cyclooxygenase inhibiting activity |
| 02/09/2006 | WO2006013073A1 Alkyl-and piperidine-substituted benzimidazole-derivates |
| 02/09/2006 | WO2002088316A3 G-protein coupled receptors |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030598 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 02/09/2006 | US20060030592 I-Oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels |
| 02/09/2006 | US20060030580 Contacting phenolic piperidines with opioid receptors; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction |
| 02/09/2006 | US20060030576 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| 02/09/2006 | US20060030561 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 02/09/2006 | US20060030546 antiallergen, viricide, herbicide, autoimmune diseases; screening procedure for the identification of enzymes GcpE and LytB inhibitor; 4-hydroxy-3-methyl-2-butenyl 1-pyrophosphate; precursor of higher isoprenoids in 2-methyl-D-erythritol pathway (MEP) |
| 02/09/2006 | US20060030045 Antisense modulation of c/ebp beta expression |
| 02/09/2006 | US20060030005 C3b/C4b complement receptor-like molecules and uses thereof |
| 02/09/2006 | US20060029687 comprises a carrier essentially formed of water, ethoxydiglycol and propylene glycol; anti-oxidant; high stirring speed provides for micronizaton of the components, which is responsible for the stability of the solutions |
| 02/09/2006 | US20060029623 Invert emulsions comprising at least one active agent sensitive to water and cosmetic/dermatological applications thereof |
| 02/09/2006 | US20060029595 Methods of using human receptor protein 4-1BB |
| 02/09/2006 | US20060029593 Immunoglobulins having complementarity determining regions, heavy and light chain variable regions from humans that specifically bind to an antigen with affinity, used for in vivo therapy and diagnosis |
| 02/09/2006 | US20060029581 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 02/09/2006 | DE69717294C5 Chinazolin derivate und diese enthaltende pharmazeutische zusammenstellungen Quinazoline derivatives and those containing pharmaceutical assortments |
| 02/09/2006 | DE102004043463A1 Differentiation of proteins, for use in diagnosis of cancer, comprises separating antigens from specimen electrophoretically and reacting with antibody composition |
| 02/09/2006 | DE102004036913A1 Verwendung von Pentameren zur Herstellung eines Medikaments Use of pentamers for the preparation of a medicament |
| 02/09/2006 | CA2573573A1 Fused ring heterocycle kinase modulators |
| 02/09/2006 | CA2573362A1 Pyrrolo-pyridine kinase modulators |
| 02/09/2006 | CA2572740A1 Alkyl-and piperidine-substituted benzimidazole-derivates |
| 02/09/2006 | CA2571937A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
| 02/08/2006 | EP1624068A1 Genetic immunization with cationic lipids |
| 02/08/2006 | EP1624057A2 Process for the obtention of a composition containing hyaluronidase |
| 02/08/2006 | EP1623987A1 Fused pyrido[3',2':4,5]thieno[3,2-d]pyrimidines and pyrido[3',2':4,5]furo[3,2-d]pyrimidines |
| 02/08/2006 | EP1623721A1 Effector cell function inhibitor |
| 02/08/2006 | EP1623710A1 Receptor antagonist |
| 02/08/2006 | EP1623011A2 IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES |
| 02/08/2006 | EP1622867A1 N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists |
| 02/08/2006 | EP1622866A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
| 02/08/2006 | EP1622860A1 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 02/08/2006 | EP1622684A2 Compositions and methods relating to novel compounds and targets thereof |
| 02/08/2006 | EP1622646A2 Treatment of lupus targeting the macrophages or the folate receptor |
| 02/08/2006 | EP1622643A2 Avian combination-vaccine against e. coli and salmonella |
| 02/08/2006 | EP1622633A2 Treatment of t-cell mediated diseases |
| 02/08/2006 | EP1478393A4 Anti-pathogen treatements |
| 02/08/2006 | EP1406865B1 Succinic acid derivatives |
| 02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
| 02/08/2006 | EP1187815B1 4-phenyl-pyrimidine derivatives |